BCL6 and diffuse large B-cell lymphoma: Similarly, the BCL6 inhibitors 79-6 (9) and its subsequent development, FX-1 (36) have antiproliferative effects on several DLBCL cell lines, whereas others have found that small-molecule BCL6 inhibitors have only weak antiproliferative activity across panels of cell lines (39).